相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias
M. Bibl et al.
MOLECULAR PSYCHIATRY (2007)
The enigma of vascular cognitive disorder and vascular dementia
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2007)
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia
Gustavo C. Roman et al.
NEUROBIOLOGY OF AGING (2006)
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
M. Bibl et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Cerebrospinal fluid amyloidβ42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia
Danielle de Jong et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
M Bibl et al.
BRAIN (2006)
Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides
M Bibl et al.
ELECTROPHORESIS (2004)
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study
H Hampel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
β-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
J Wiltfang et al.
ANNALS OF NEUROLOGY (2003)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients - An ultrasensitive bienzyme-substrate-recycle enzyme-linked Immunosorbent assay
YY Hu et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Alzheimer disease as a vascular disorder - Nosological evidence
JC de la Torre
STROKE (2002)
Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia
K Nagga et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
Cerebral microvascular pathology in aging and Alzheimer's disease
E Farkas et al.
PROGRESS IN NEUROBIOLOGY (2001)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
N Andreasen et al.
ARCHIVES OF NEUROLOGY (2001)
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid:: a sandwich ELISA with a synthetic phosphopeptide for standardization
E Vanmechelen et al.
NEUROSCIENCE LETTERS (2000)
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
M Sjogren et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
